Objectif Investigation of the clinical prognostic value of soluble urokinase plasminogen activator receptor (uPAR) forms in blood and tissue extracts from patients with colon and breast cancer, aiming to develop new methods which will aid in the decision-making needed in the management of cancer patients. Champ scientifique sciences médicales et de la santémédecine cliniqueoncologiecancer du sein Programme(s) FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002 Thème(s) 1.1.1.-4. - Key action Environment and Health Appel à propositions Data not available Régime de financement RGI - Research grants (individual fellowships) Coordinateur COPENHAGEN UNIVERSITY HOSPITAL Adresse Stransboulevarden 49 2100 Koepenhagen Danemark Voir sur la carte Contribution de l’UE Aucune donnée
